Image_5_Decreased Evoked Slow-Activity After tDCS in Disorders of Consciousness.PNG by Armand Mensen (516668)

Image_3_Decreased Evoked Slow-Activity After tDCS in Disorders of Consciousness.PNG by Armand Mensen (516668)

Image_2_Decreased Evoked Slow-Activity After tDCS in Disorders of Consciousness.PNG by Armand Mensen (516668)

Tissue-specific profiling of the photoreceptor nuclear transcriptome reveals significant changes in early and late aging. by Juan Jauregui-Lozano (12024868)

Image_1_Loneliness predicts decreased physical activity in widowed but not married or unmarried individuals.TIF by Chava Pollak (18478155)

“…Loneliness did not predict a statistically significant decrease in physical activity in married or unmarried individuals.…”

Table_1_Decreased Incidence of Intraventricular Hemorrhage in Extremely Low Birth Weight Infants Using Customized Circulatory Management to Evaluate the Hemodynamic Change of Paten... by Wan-Heng Huang (11504539)

“…Other outcomes showed no significant differences. Dobutamine was prescribed in 8 cases in the management group, and end-systolic wall stress (ESWS) was significantly decreased after Dobutamine administration (p = 0.017).…”

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Table_4_Good News — Bad News: Combined Ocean Change Drivers Decrease Survival but Have No Negative Impact on Nutritional Value and Organoleptic Quality of the Northern Shrimp.pdf by Mathilde Chemel (9190907)

Table_3_Good News — Bad News: Combined Ocean Change Drivers Decrease Survival but Have No Negative Impact on Nutritional Value and Organoleptic Quality of the Northern Shrimp.pdf by Mathilde Chemel (9190907)

Spatially Resolved Dissolution and Speciation Changes of ZnO Nanorods during Short-Term <i>in Situ</i> Incubation in a Simulated Wastewater Environment by Miguel A. Gomez-Gonzalez (7410050)

Subjects:

Occurrence and Composition Patterns of ARGs in Plant-Microbial Synergism Were Negatively Reconstructed by an Electrochemical Technology at Low Temperatures by Na Zhang (333280)

Subjects:

Trends of Full-Volatility Organic Emissions in China from 2005 to 2019 and Their Organic Aerosol Formation Potentials by Haotian Zheng (6934553)

Subjects:

Number of participants showing improved, decreased, or no change in task performance with and without PSAPs. by Maxime Perron (16618003)

After moderate and severe TBI, PWI revealed CBF was significantly decreased in the ipsilateral cortex and hippocampus at several time points relative to sham animals. by Juliana Sanchez-Molano (16792787)

Patient characteristics for OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects:

Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

Subjects:

Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

Subjects:

Normalized significant family changes in abundance. by Karley K. Mahalak (3212670)